Fig. 4.

Time to progression comparing patients with recurrent World Health Organization (WHO) grade II to those with initially diagnosed WHO grade III meningioma. The percentages accompanying the curves are annual actuarial results, from 1 to 5 years after study registration. Used with permission from NRG Oncology.